These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 21084965)
1. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. Lee AF; Hayes MM; Lebrun D; Espinosa I; Nielsen GP; Rosenberg AE; Lee CH Appl Immunohistochem Mol Morphol; 2011 May; 19(3):233-8. PubMed ID: 21084965 [TBL] [Abstract][Full Text] [Related]
2. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations. Devaney K; Vinh TN; Sweet DE Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935 [TBL] [Abstract][Full Text] [Related]
3. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study. Syed M; Mushtaq S; Loya A; Hassan U Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222 [TBL] [Abstract][Full Text] [Related]
4. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Machado I; Navarro S; Picci P; Llombart-Bosch A Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787 [TBL] [Abstract][Full Text] [Related]
6. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Hung YP; Fletcher CD; Hornick JL Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513 [TBL] [Abstract][Full Text] [Related]
8. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943 [TBL] [Abstract][Full Text] [Related]
9. Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma. Machado I; López Guerrero JA; Navarro S; Mayordomo E; Scotlandi K; Picci P; Llombart-Bosch A Virchows Arch; 2013 Jun; 462(6):665-71. PubMed ID: 23681112 [TBL] [Abstract][Full Text] [Related]
10. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors. Chebib I; Jo VY Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124 [TBL] [Abstract][Full Text] [Related]
11. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993 [TBL] [Abstract][Full Text] [Related]
12. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model. Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560 [TBL] [Abstract][Full Text] [Related]
13. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases. Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883 [TBL] [Abstract][Full Text] [Related]
14. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. Machado I; Navarro L; Pellin A; Navarro S; Agaimy A; Tardío JC; Karseladze A; Petrov S; Scotlandi K; Picci P; Llombart-Bosch A Ann Diagn Pathol; 2016 Jun; 22():25-32. PubMed ID: 27180056 [TBL] [Abstract][Full Text] [Related]
15. Ewing sarcoma and Ewing-like tumors. Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230 [TBL] [Abstract][Full Text] [Related]
16. Oncostatin M is a growth factor for Ewing sarcoma. David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441 [TBL] [Abstract][Full Text] [Related]
17. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma. Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596 [TBL] [Abstract][Full Text] [Related]
18. Small round cell lesions of the bone: Diagnostic approach, differential diagnoses and impact on treatment. Rekhi B; Mridha A; Kattoor J Indian J Pathol Microbiol; 2019; 62(2):199-205. PubMed ID: 30971540 [TBL] [Abstract][Full Text] [Related]